» Articles » PMID: 30443019

Control and Dysregulation of Redox Signalling in the Gastrointestinal Tract

Overview
Specialty Gastroenterology
Date 2018 Nov 17
PMID 30443019
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

Redox signalling in the gastrointestinal mucosa is held in an intricate balance. Potent microbicidal mechanisms can be used by infiltrating immune cells, such as neutrophils, to protect compromised mucosae from microbial infection through the generation of reactive oxygen species. Unchecked, collateral damage to the surrounding tissue from neutrophil-derived reactive oxygen species can be detrimental; thus, maintenance and restitution of a breached intestinal mucosal barrier are paramount to host survival. Redox reactions and redox signalling have been studied for decades with a primary focus on contributions to disease processes. Within the past decade, an upsurge of exciting findings have implicated subtoxic levels of oxidative stress in processes such as maintenance of mucosal homeostasis, the control of protective inflammation and even regulation of tissue wound healing. Resident gut microbial communities have been shown to trigger redox signalling within the mucosa, which expresses similar but distinct enzymes to phagocytes. At the fulcrum of this delicate balance is the colonic mucosal epithelium, and emerging evidence suggests that precise control of redox signalling by these barrier-forming cells may dictate the outcome of an inflammatory event. This Review will address both the spectrum and intensity of redox activity pertaining to host-immune and host-microbiota crosstalk during homeostasis and disease processes in the gastrointestinal tract.

Citing Articles

Orally Administrated Inulin-Modified Nanozymes for CT-Guided IBD Theranostics.

Li X, Cao L, Li J, Li Z, Ma H, Cheng S Int J Nanomedicine. 2025; 20:2119-2131.

PMID: 39990289 PMC: 11846537. DOI: 10.2147/IJN.S497558.


Preeclampsia as a Study Model for Aging: The Klotho Gene Paradigm.

Cecati M, Fumarola S, Vaiasicca S, Cianfruglia L, Vignini A, Giannubilo S Int J Mol Sci. 2025; 26(3).

PMID: 39940672 PMC: 11817256. DOI: 10.3390/ijms26030902.


Neutrophils: From Inflammatory Bowel Disease to Colitis-Associated Colorectal Cancer.

Chen T, Liu J, Hang R, Chen Q, Wang D J Inflamm Res. 2025; 18:925-947.

PMID: 39871958 PMC: 11770381. DOI: 10.2147/JIR.S497701.


The Triad of Risk: Linking MASLD, Cardiovascular Disease and Type 2 Diabetes; From Pathophysiology to Treatment.

Michalopoulou E, Thymis J, Lampsas S, Pavlidis G, Katogiannis K, Vlachomitros D J Clin Med. 2025; 14(2).

PMID: 39860434 PMC: 11765821. DOI: 10.3390/jcm14020428.


The mycobiome in human cancer: analytical challenges, molecular mechanisms, and therapeutic implications.

Ding T, Liu C, Li Z Mol Cancer. 2025; 24(1):18.

PMID: 39815314 PMC: 11734361. DOI: 10.1186/s12943-025-02227-8.


References
1.
Birchenough G, Johansson M, Gustafsson J, Bergstrom J, Hansson G . New developments in goblet cell mucus secretion and function. Mucosal Immunol. 2015; 8(4):712-9. PMC: 4631840. DOI: 10.1038/mi.2015.32. View

2.
Jones R, Desai C, Darby T, Luo L, Wolfarth A, Scharer C . Lactobacilli Modulate Epithelial Cytoprotection through the Nrf2 Pathway. Cell Rep. 2015; 12(8):1217-25. PMC: 4640184. DOI: 10.1016/j.celrep.2015.07.042. View

3.
Barman M, Unold D, Shifley K, Amir E, Hung K, Bos N . Enteric salmonellosis disrupts the microbial ecology of the murine gastrointestinal tract. Infect Immun. 2007; 76(3):907-15. PMC: 2258829. DOI: 10.1128/IAI.01432-07. View

4.
Saitoh T, Fujita N, Jang M, Uematsu S, Yang B, Satoh T . Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature. 2008; 456(7219):264-8. DOI: 10.1038/nature07383. View

5.
Kirienko N, Kirienko D, Larkins-Ford J, Wahlby C, Ruvkun G, Ausubel F . Pseudomonas aeruginosa disrupts Caenorhabditis elegans iron homeostasis, causing a hypoxic response and death. Cell Host Microbe. 2013; 13(4):406-16. PMC: 3641844. DOI: 10.1016/j.chom.2013.03.003. View